Page last updated: 2024-10-31

mitoxantrone and Vaginal Neoplasms

mitoxantrone has been researched along with Vaginal Neoplasms in 1 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Vaginal Neoplasms: Tumors or cancer of the VAGINA.

Research Excerpts

ExcerptRelevanceReference
"Mitoxantrone displays no activity in patients with advanced carcinoma of the vulva or vagina."1.28Mitoxantrone in the treatment of advanced vulvar and vaginal carcinoma. A gynecologic oncology group study. ( Bundy, BN; Christopherson, WA; Muss, HB, 1989)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Muss, HB1
Bundy, BN1
Christopherson, WA1

Other Studies

1 other study available for mitoxantrone and Vaginal Neoplasms

ArticleYear
Mitoxantrone in the treatment of advanced vulvar and vaginal carcinoma. A gynecologic oncology group study.
    American journal of clinical oncology, 1989, Volume: 12, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Carcinoma, Squamous Cell; Female; Humans; Infusions, In

1989